Cite
HARVARD Citation
Gramatica, A. et al. (n.d.). D-109 Defining a potent new class of latency reversing agents devoid of toxicity and detrimental cell activation that enhance CTL/NK cell killing. Journal of acquired immune deficiency syndromes. p. . [Online].